Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma

被引：0
|
作者：
Willson, Jenny [1 ]
Bruno, Amanda [2 ]
Opalinska, Joanna [3 ]
Nelson, Jeannene [4 ]
Lunacsek, Orsolya [5 ]
Stafkey-Mailey, Dana [5 ]
Willey, Joanne [5 ]
机构：
[1] GlaxoSmithKline, Brentford, England
[2] GlaxoSmithKline, Warren, NJ USA
[3] GlaxoSmithKline, Collegeville, PA USA
[4] GlaxoSmithKline, Res Triangle Pk, NC USA
[5] Xcenda, Palm Harbor, FL USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-112954
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3290
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Real-world assessment of treatment patterns and outcomes in patients with lenalidomide-refractory relapsed multiple myeloma from the SEER-Medicare database
    Dhakal, Binod
    Einsele, Hermann
    Potluri, Ravi
    Schecter, Jordan
    Deraedt, William
    Lendvai, Nikoletta
    Slaughter, Ana
    Lonardi, Carolina
    Nair, Sandhya
    He, Jianming
    Voelker, Jennifer
    Cost, Patricia
    Valluri, Satish
    Yalniz, Fevzi
    Pacaud, Lida
    Yong, Kwee
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S167 - S167
  • [22] Real-world outcomes of daratumumab monotherapy in relapsed/refractory myeloma
    Maouche, N.
    Leary, H.
    Collings, F.
    Tseu, B.
    Djebbari, F.
    Vallance, G.
    Ramasamy, K.
    Kothari, J.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 125 - 125
  • [23] Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
    Huang, Shang-Yi
    Chen, Tsai-Yun
    Kuo, Ching-Yuan
    Chen, Yeu-Chin
    Lin, Sheng-Fung
    Chang, Ming-Chih
    Lv, Xinzhu
    Yang, Betty
    Chang, Cheng-Shyong
    [J]. ONCOLOGY REVIEWS, 2019, 13 (01) : 15 - 22
  • [24] Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma, a Real-World Experience
    Hultcrantz, Malin
    Orozco, Jennifer
    Peterson, Tim J.
    Derkach, Andriy
    Hassoun, Hani
    Korde, Neha
    Lu, Sydney X.
    Mailankody, Sham
    Patel, Dhwani
    Shah, Urvi A.
    Tan, Carlyn
    Maclachlan, Kylee H.
    Chung, David J.
    Landau, Heather J.
    Shah, Gunjan L.
    Lahoud, Oscar B.
    Scordo, Michael
    Landgren, Ola
    Giralt, Sergio
    Lesokhin, Alexander
    [J]. BLOOD, 2021, 138
  • [25] Evaluation of Efficacy Outcomes Among Relapsed/ Refractory Multiple Myeloma Treated Patients in a Real-World Setting
    Nooka, Ajay
    Voorhees, Peter M.
    Kumar, Shaji K.
    Mehra, Maneesha
    Lam, Annette
    Slavcev, Mary
    Ukropec, Jon
    Potluri, Ravi
    Dasgupta, Anandaroop
    [J]. BLOOD, 2017, 130
  • [26] POMALIDOMIDE OR CARFILZOMIB USE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: REAL-WORLD TREATMENT PATTERNS, TIME TO NEXT TREATMENT, AND ECONOMIC OUTCOMES
    Parikh, K.
    Purnomo, L.
    Abouzaid, S.
    Chen, C. C.
    McGuiness, C.
    Hussein, M.
    Wade, R.
    [J]. HAEMATOLOGICA, 2016, 101 : 603 - 603
  • [27] Real-world outcomes of venetoclax refractory multiple myeloma patients.
    Maples, Kathryn T.
    Kaufman, Jonathan L.
    Gupta, Vikas Anand
    Joseph, Nisha
    Heffner, Leonard T.
    Hofmeister, Craig C.
    Dhodapkar, Madhav, V
    Matulis, Shannon M.
    Boise, Lawrence
    Lonial, Sagar
    Nooka, Ajay K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Real-World Treatment Patterns in Relapsed or Refractory Multiple Myeloma: Evidence from a Cohort Review in the United Kingdom
    Lin, Huamao Mark
    Davis, Keith L.
    Kaye, James A.
    Luptakova, Katarina
    Nagar, Saurabh
    Seal, Brian
    [J]. BLOOD, 2016, 128 (22)
  • [29] Real-world treatment patterns and clinical outcomes in patients with triple-class exposed relapsed or refractory multiple myeloma in United States clinical practice
    Chari, Ajai
    Nair, Sandhya
    Lin, Xiwu
    Marshall, Alexander
    Slavcev, Mary
    Kumar, Shaji
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S165 - S166
  • [30] KarMMa-RW: A study of real-world treatment patterns in heavily pretreated patients with Relapsed and Refractory Multiple Myeloma (RRMM) and comparison of outcomes to KarMMa
    Goldschmidt, H.
    Jagannath, S.
    Lin, Y.
    Reece, D.
    Nooka, A.
    Senin, A.
    Rodriguez Otero, P.
    Powles, R.
    Matsue, K.
    Shah, N.
    Anderson, L., Jr.
    Wilson, K.
    Le, H., V
    Agarwal, A.
    Siegel, D. S.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 93 - 93
12345